XCE Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist with CAS number 2023788-19-2. This research compound shows potential for improving glycemic control through its unique mechanism of action.
Our XCE Tirzepatide is supplied as a white powder with purity exceeding 99%, as verified by HPLC analysis. The product is manufactured under strict quality control standards for research applications only.
Storage recommendations for XCE Tirzepatide include maintaining the product in a dry, dark environment at 0-4°C for short-term storage or -20°C for long-term preservation. Proper storage conditions are essential for maintaining peptide stability.
As a research chemical, XCE Tirzepatide is intended solely for laboratory use and scientific investigation. This product is not for human consumption or diagnostic use.
Our manufacturing facility specializes in peptide synthesis and offers bulk quantities of XCE Tirzepatide for research institutions and pharmaceutical developers. We maintain comprehensive documentation including Certificates of Analysis for all batches.
The dual agonist properties of XCE Tirzepatide make it particularly interesting for metabolic research applications. Current studies focus on its potential effects on glucose regulation and weight management pathways.